DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Walter E. Washington Convention Center

2015 年 06 月 14 日 2:30 下午 - 2015 年 06 月 18 日 6:45 下午

801 Mount Vernon Place, NW, , Washington, DC 20001-3614 , USA

DIA 2015 51st Annual Meeting: Develop. Innovate. Advance.

Full conference and one-day registrants will have access to presentation PDFs through Friday, December 18, 2015 <A href="http://www.diaglobal.org/Flagship-Meetings/DIA-Annual-Meeting/Meeting-Program/ePac-Presentations-Access.aspx">Review Presentations </A>

The Role of Labeling in Successful Human Factors Studies

Session Chair(s)

Eileen  Kahn, BSN, MSc

Eileen Kahn, BSN, MSc

Sr. Manager, Global Regulatory Labeling

Consultant, United States

A key component of well-designed, successful human factors studies is having clear and concise labeling so the patient can use the device safely and effectively. This forum will provide some industry perspectives in how this can be accomplished.

Learning Objective : Discuss how to develop patient labeling in correlation with the device development in order to have a successful human factors (HF) study; Explain how to implement labeling changes resulting from the HF study; Identify what labeling changes can be made without affecting the validity of the HF study including what choices are available if it does, such as a bridging study.

Speaker(s)

Renee  Bailey

Panelist

Renee Bailey

Agilis Consulting Group, LLC, United States

Director, Instructional Design & Creative Solutions

Molly Follette Story, PhD, MS

Panelist

Molly Follette Story, PhD, MS

Sanofi , United States

Senior Advisor, Medical Device Development Unit

Irene Z. Chan, PharmD

Panelist

Irene Z. Chan, PharmD

FDA, United States

Director (Acting), Division of Medication Error Prevention and Analysis 1, OSE,

注册方法

Registration override should work.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。